Neoplasms of the GB, Liver, Pancreas Flashcards

1
Q

What is the gross appearance of Focal nodular hyperplasia?

A

Well-demarcated

central, depressed stellate scar

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What demographic (age, gender) is focal nodular hyperplasia most common??

A

F>M, 30-50 yo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What liver pathology is Focal nodular hyperplasia a/w?

A

vascular lesions of liver (hyperperfused)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the most common benign neoplasm of the liver? what is the gross appearance?

A

Cavernous hemangiomas
soft red-blue subcapsular nodule (<2cm)

mistaken for metastasis (on imaging, surgery)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the risks for developing Hepatocellular adenoma?

A

oral contraceptives/anabolic steroids

cessation can lead to complete regression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the gross appearance of hepatocellular ADENOMA?

A

well demarcated (encapsulated)
often:
1. hypovascular
2. large (>6 cm)
3. hemorrage + necrosis (Coagulative)
4. arranged in CORDS (trabeculae) <2 cell layers thick
—if cord is thicker than 2 cells = CARCINOMA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the 3 subtypes of Hepatocellular adenoma?

A
  1. HNF1-a inactivation
  2. B-catenin activation
  3. Inflammatory
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Stratify the malignancy risk of HNF1-a inactivation, B-catenin activation, and Inflammatory Hepatocellular adenoma.

A
  1. B-catenin activation!!!!!!!! >
  2. Inflammatory >
  3. HNF1-a inactivation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are characteristics of HNF1-a inactivation hepatocellular adenomas?

A

fatty liver nodules
a/w MODY-3
least malignancy risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are characteristics of Inflammatory Hepatocellular adenomas?

A

JAK/STATE pathway mutations
–mutations in GP130 (coreceptor for IL-6)
small risk of malignant transformation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the difference between Large cell change and Small cell change as precursors to Hepatocellular Carcinoma?

A

Large Cell:

  • normal N:C ratio
  • near portal tracts

Small Cell:

  • higher N:C ratio
  • small expansive nodules
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are characteristics of High-grade dysplastic precursors to HCC?

A

cytologic/architectural atypia
(pseudoglands, trabecular thickening)

greater hepatic arterial blood supply

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the most common PRIMARY liver malignancy?

what are rates of occurrence correlated with?

A
Hepatocellular carcinoma (HCC)
-occurs in contest of cirrhosis

Risks:
Male
Countries with high rates of HBV, HCV or AFLATOXIN (Aspergillus mycotoxin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are 3 histopathologic features of HCC?

A
  1. cytologic atypia, increased N:C ratio
  2. Thickened hepatocyte trabeculae (>2 cells)
  3. Pseudoacini (pseudoglands) - hemorrhage/necrosis, lack portal areas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are 3 pathogenic causes of HCC from chronic liver disease?

A
  1. HBC, HCV/aflatoxin/EtOH - synergistic damage
  2. TP53 mutations - MOST COMMON early event
  3. IL-6/JAK/STAT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are clinical features and radiology of HCC?

A

clinical features:
abdominal pain, malaise, weight loss, jaundice

radiology
U/S: nodules
CT/MRI w/ contrast - increased arterialization

17
Q

What is the prognosis of HCC? how does it metastasize?

A

poor prognosis

Metastasis: via hepatic venous system (to lung)

18
Q

What is the demographic of Fibrolamellar variant of HCC? what is the prognosis?

A

younger (<35)

favorable prognosis

19
Q

What is the most common liver tumor in children (<3 yo)? what is the tumor histopathology?

A

Hepatoblastoma

histo: primitive, fetal-type tissue

20
Q

what is the gene mutation of hepatoblastoma?

A

APC (Wnt signalling pathway)

21
Q

What is a cholangiocarcinoma? What are risks?

A

tumor of bile duct epithelium
-90% Extrahepatic (Klatskin tumor: perihilar)

Risks:
Liver fluke
Inflammatory: PSC, PBC, hepatolithiasis, fibrocystic
HBV, HCV
NAFLD
22
Q

What is the the clinical presentation and prognosis of Cholangiocarinoma?

A

Sx: Abd pain, weightloss
JAUNDICE - Conjugated bilirubin predominant (obstructive)
Older pts
RARELY presents with cirrhosis

Prognosis: dismal

23
Q

What is the most common form of Gallbladder Neoplasms? What is the epidemiology, and risk factors?

A

Adenocarcinomas
Epidem: Native American, Hispanic
F>M

Risks: chronic inflammation (CHOLELITHIASIS)

24
Q

What is the molecular pathogenesis of Gallbladder Carcinomas? what is Tx?

A

Overespression of ERBB2 (Her-2/neu) receptor

Tx: Trastuzumab

25
What accounts for 75% of pancreatic cysts? what are some characteristics of it?
Pancreatic Pseudocysts 1. Lack epithelial lining (from constant destruction/repair: pancreatitis) 2. Cyst fluid high in LIPASE, AMYLASE
26
What are 3 types of Benign cystic neoplasms of pancreas?
1. Serous cystic neoplasms 2. Mucinous cystic neoplasms 3. Intraductal papillar mucinous neoplasms (IPMN)
27
What are some characteristics of Serous cystic neoplasms of pancreas?
1. uniformly benign 2. multicystic (grossly: Spongy) 3. Tail of pancreas 4. VHL gene mutation
28
What are some characteristics of Mucinous cystic neoplasms of pancreas?
``` F>>M precursor to malignant lesion arise in TAIL KRAS, TP53 mutations Hist: thick, tenacious mucin, columnar cells w wall of dense stroma (similar to ovarian stroma) ```
29
What are some characteristics of Intraductal Papillary Mucinous Neoplasms (IPMN) of pancreas?
1. M>F 2. Head of Pancreas > tail 3. arise within large pancreatic ducts 4. Can progress to invasive cancer 5. KRAS, TP53 mutations
30
What are is the pathogenesis of Pancreatic intraepithelial neoplasia (PanIn) => PANCREATIC CANCER
progressive telomeric shortening KRAS, TP53 mutations model for progression: PanIn I, II, III
31
Where is pancreatic cancer most commonly located?
60% in head | distant metastasis to liver and lung
32
What is the clinical Sx of pancreatic Cancer?
typically "silent" before metastasis Sx: "Painless Jaundice (obstructive) w weightloss) Trousseau sign: migratory thrombophlebitis Labs: serum CA 19-9, CEA